Cancer prevention and treatment for people living with HIV
Consortium for Advancing Management and Prevention of Cancer in People with HIV
Trying new ways to prevent and treat cancers that affect people living with HIV through clinical trials and community partnerships.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11406610 on NIH RePORTER |
What this research studies
If I have HIV, I could join clinical trials run by this consortium to try new treatments or prevention methods for cancers such as anal cancer. Researchers may collect blood, tissue, and medical information to learn how these cancers start and respond to therapy. The consortium runs trials at 39 sites across the U.S., sub-Saharan Africa, and Latin America and has enrolled thousands of participants. Patient advocates and a global community advisory board help shape study plans and participant support.
Who could benefit from this research
Good fit: People living with HIV who have or are at risk for HIV-associated cancers (for example anal cancer) and who can attend one of the consortium's participating trial sites.
Not a fit: People without HIV, those with cancers not targeted by the consortium's trials, or individuals unable to access participating sites are unlikely to benefit directly from joining these trials.
Why it matters
Potential benefit: Could reduce cancer rates and improve treatment outcomes for people living with HIV if trials identify effective prevention or therapy approaches.
How similar studies have performed: Yes — the consortium has conducted over 97 interventional trials with more than 10,700 participants and produced publications that have changed clinical practice in the U.S. and low- and middle-income countries.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.